NeuroFlex Podcast

Steven Feinberg, PhD. is a Neurostrategist, Executive Coach and High Performance Team builder for some of the sharpest, smartest brains and businesses in America. He works with CEO’s, senior executives and business founders, from billion-dollar Corporate 500s to young and hungry entrepreneurial start-ups, across brands like Oracle, Google, LinkedIn, Wells Fargo, Hitachi and Xero, ranked Number 1 innovation Start-up.

Steven Feinberg, PhD. is a Neurostrategist, Executive Coach and High Performance Team builder for some of the sharpest, smartest brains and businesses in America. He works with CEO’s, senior executives and business founders, from billion-dollar Corporate 500s to young and hungry entrepreneurial start-ups, across brands like Oracle, Google, LinkedIn, Wells Fargo, Hitachi and Xero, ranked Number 1 innovation Start-up.

As a dynamic and socially-conscious entrepreneur, Patrick uses creativity and a passion for human connectivity to unite individuals across social and corporate spectrums. His superpower is making solid introductions that create meaningful outcomes and amplify impact. He’s currently President at Microdose Psychedelic Insights, developing the industry’s premier events and media platform alongside a highly motivated and engaged startup team. 

He’s spoken at the Concordia Annual Summit 2022 in New York, the first Medical Psychedelic House of Davos in Switzerland, Burning Man in Nevada, Wonderland Miami, and Plant Medicine Week in Malta. Having evolved from a successful career in photography and co-founding a few cannabis companies, Patrick’s focus is helping businesses achieve financial success while supporting nonprofits & charities in emerging industries. He currently sits on the board of directors for Heroic Hearts Project Canada, and advisory board for the Plant Medicine Coalition in support of their work.

https://microdose.buzz

As a dynamic and socially-conscious entrepreneur, Patrick uses creativity and a passion for human connectivity to unite individuals across social and corporate spectrums. His superpower is making solid introductions that create meaningful outcomes and amplify impact. He’s currently President at Microdose Psychedelic Insights, developing the industry’s premier events and media platform alongside a highly motivated and engaged startup team. 

He’s spoken at the Concordia Annual Summit 2022 in New York, the first Medical Psychedelic House of Davos in Switzerland, Burning Man in Nevada, Wonderland Miami, and Plant Medicine Week in Malta. Having evolved from a successful career in photography and co-founding a few cannabis companies, Patrick’s focus is helping businesses achieve financial success while supporting nonprofits & charities in emerging industries. He currently sits on the board of directors for Heroic Hearts Project Canada, and advisory board for the Plant Medicine Coalition in support of their work.

https://microdose.buzz

Dr. Jill Carnahan is Your Functional Medicine Expert® and author of Unexpected (March 2023), is the leading voice in mold and mold-related illness and often referred to as "The Sherlock Holmes of Medicine." In fact, she was recently featured in People Magazine for solving the medical mystery behind ABC's The Bachelorette's Ryan Sutter's years long battle with Lyme Disease.

Dr. Jill is double board-certified in Family Medicine and Integrative Holistic Medicine and has sustained a 5+ year waiting list as the Medical Director of Flatiron Functional Medicine, a widely sought-after practice. She uses nutritional protocols and supplements, lifestyle changes, and medication to increase patient level of function and always seeks the gentlest and least invasive way to restore health and optimize healing. 

As a survivor of breast cancer, Crohn’s disease, and toxic mold illness, Dr. Jill brings a unique perspective to treating a variety of complex and chronic illness and has traveled the world sharing her knowledge of hope, health and healing live on stage as well as through newsletters, articles, books, podcasts, and social media.

https://www.drjillhealth.com

Dr. Jill Carnahan is Your Functional Medicine Expert® and author of Unexpected (March 2023), is the leading voice in mold and mold-related illness and often referred to as "The Sherlock Holmes of Medicine." In fact, she was recently featured in People Magazine for solving the medical mystery behind ABC's The Bachelorette's Ryan Sutter's years long battle with Lyme Disease.

Dr. Jill is double board-certified in Family Medicine and Integrative Holistic Medicine and has sustained a 5+ year waiting list as the Medical Director of Flatiron Functional Medicine, a widely sought-after practice. She uses nutritional protocols and supplements, lifestyle changes, and medication to increase patient level of function and always seeks the gentlest and least invasive way to restore health and optimize healing. 

As a survivor of breast cancer, Crohn’s disease, and toxic mold illness, Dr. Jill brings a unique perspective to treating a variety of complex and chronic illness and has traveled the world sharing her knowledge of hope, health and healing live on stage as well as through newsletters, articles, books, podcasts, and social media.

https://www.drjillhealth.com

Amanda Siebert is a Vancouver-based freelance journalist and author whose work has appeared in the New York Times, the Georgia Straight, VICE, and more. Her first book, The Little Book of Cannabis: How Marijuana Can Improve Your Life, was published in 2018 and she just released her newest book Psyched: Seven Cutting Edge Psychedelics Changing the World earlier this year.

https://amandasiebert.com

Amanda Siebert is a Vancouver-based freelance journalist and author whose work has appeared in the New York Times, the Georgia Straight, VICE, and more. Her first book, The Little Book of Cannabis: How Marijuana Can Improve Your Life, was published in 2018 and she just released her newest book Psyched: Seven Cutting Edge Psychedelics Changing the World earlier this year.

https://amandasiebert.com

Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration.

Algernon Pharmaceuticals plans to be the first Company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year. DMT is a "classic" psychedelic compound part of the tryptamine family.

https://algernonpharmaceuticals.com

Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration.

Algernon Pharmaceuticals plans to be the first Company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year. DMT is a "classic" psychedelic compound part of the tryptamine family.

https://algernonpharmaceuticals.com